The North America Plasma Fractionation Market would witness market growth of 8.3% CAGR during the forecast period (2021-2027). Fractionation refers to a process performed in order to separate a particular quantity of a mixture.
Moreover, plasma refers to a fluid part of blood, which is fractionated to extract various plasma derivatives like albumin and immunoglobulins. These extracted plasma products show therapeutic properties and are used to treat several blood plasma-related diseases. For example, coagulation factor VIII refers to a plasma derivative that is utilized for treating and prophylaxis of hemophilia. Moreover, it is also utilized in order to stop extreme blood loss during surgical procedures. Likewise, immunoglobulins are used in treating primary and secondary immune deficiencies.
Plasma-derived immunoglobulins are being highly utilized in various clinical indications like autoimmune and inflammatory diseases. The plasma fractionation market is putting massive investment in therapies like Plasmin, Ceruloplasmin, and IgA. Additionally, thriving investments in innovation and technological developments in effective and cost-efficient techniques for fractioning proteins will provide momentum to the plasma fractionation market.
Though, disruption in raw material supply was neutralized by a decline in demand for plasma derivatives during the onset of country-wise lockdowns, as elective surgical methods were delayed and accessibility of treatment for other medical conditions was also hindered. Additionally, the overall plasma supply in different nations is the same as before; though, some parts of the world may witness shortages. Therefore, the COVID-19 pandemic brought an adverse impact on the growth of the overall plasma fractionation market.
The US market dominated the North America Coagulation factor VIII Market by Country in 2020, thereby, achieving a market value of $787.4 Million by 2027. The Canada market is experiencing a CAGR of 12.3% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 11.4% during (2021 - 2027).
Based on Product, the market is segmented into Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX. Based on Sector, the market is segmented into Private Sector and Public Sector. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Plasma Fractionation Market is Estimated to Reach USD 28.2 Billion by 2027 at a CAGR of 9.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Emergent BioSolutions, Inc., CSL Limited, Grifols S.A., Octapharma AG, Takeda Pharmaceutical Company Limited, Kedrion S.p.A, LFB S.A, Biotest AG (Tiancheng International Investment Limited), Sanquin Blood Supply Foundation, and Bio Products Laboratory Limited.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Immunoglobulins
- Albumin
- Coagulation factor VIII
- Coagulation factor IX
By Sector
- Private Sector
- Public Sector
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Emergent BioSolutions, Inc.
- CSL Limited
- Grifols S.A.
- Octapharma AG
- Takeda Pharmaceutical Company Limited
- Kedrion S.p.A
- LFB S.A
- Biotest AG (Tiancheng International Investment Limited)
- Sanquin Blood Supply Foundation
- Bio Products Laboratory Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Plasma Fractionation Market, by Product
1.4.2 North America Plasma Fractionation Market, by Sector
1.4.3 North America Plasma Fractionation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Plasma Fractionation Market by Product
3.1 North America Immunoglobulins Market by Country
3.2 North America Albumin Market by Country
3.3 North America Coagulation factor VIII Market by Country
3.4 North America Coagulation factor IX Market by Country
Chapter 4. North America Plasma Fractionation Market by Sector
4.1 North America Private Sector Market by Country
4.2 North America Public Sector Market by Country
Chapter 5. North America Plasma Fractionation Market by Country
5.1 US Plasma Fractionation Market
5.1.1 US Plasma Fractionation Market by Product
5.1.2 US Plasma Fractionation Market by Sector
5.2 Canada Plasma Fractionation Market
5.2.1 Canada Plasma Fractionation Market by Product
5.2.2 Canada Plasma Fractionation Market by Sector
5.3 Mexico Plasma Fractionation Market
5.3.1 Mexico Plasma Fractionation Market by Product
5.3.2 Mexico Plasma Fractionation Market by Sector
5.4 Rest of North America Plasma Fractionation Market
5.4.1 Rest of North America Plasma Fractionation Market by Product
5.4.2 Rest of North America Plasma Fractionation Market by Sector
Chapter 6. Company Profiles
6.1 Emergent BioSolutions, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.2 CSL Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Grifols S.A.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.1 Recent strategies and developments:
6.3.1.1 Acquisition and Mergers:
6.4 Octapharma AG
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Approvals:
6.4.2.2 Partnerships, Collaborations, and Agreements:
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.6 Kedrion S.p.A
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 LFB S.A.
6.7.1 Company Overview
6.8 Biotest AG (Tiancheng International Investment Limited)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Sanquin Blood Supply Foundation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Bio Products Laboratory Limited
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Product Launches and Product Expansions:
TABLE 1 North America Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 2 North America Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 3 North America Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 4 North America Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 5 North America Immunoglobulins Market by Country, 2017 - 2020, USD Million
TABLE 6 North America Immunoglobulins Market by Country, 2021 - 2027, USD Million
TABLE 7 North America Albumin Market by Country, 2017 - 2020, USD Million
TABLE 8 North America Albumin Market by Country, 2021 - 2027, USD Million
TABLE 9 North America Coagulation factor VIII Market by Country, 2017 - 2020, USD Million
TABLE 10 North America Coagulation factor VIII Market by Country, 2021 - 2027, USD Million
TABLE 11 North America Coagulation factor IX Market by Country, 2017 - 2020, USD Million
TABLE 12 North America Coagulation factor IX Market by Country, 2021 - 2027, USD Million
TABLE 13 North America Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 14 North America Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 15 North America Private Sector Market by Country, 2017 - 2020, USD Million
TABLE 16 North America Private Sector Market by Country, 2021 - 2027, USD Million
TABLE 17 North America Public Sector Market by Country, 2017 - 2020, USD Million
TABLE 18 North America Public Sector Market by Country, 2021 - 2027, USD Million
TABLE 19 North America Plasma Fractionation Market by Country, 2017 - 2020, USD Million
TABLE 20 North America Plasma Fractionation Market by Country, 2021 - 2027, USD Million
TABLE 21 US Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 22 US Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 23 US Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 24 US Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 25 US Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 26 US Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 27 Canada Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 28 Canada Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 29 Canada Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 30 Canada Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 31 Canada Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 32 Canada Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 33 Mexico Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 34 Mexico Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 35 Mexico Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 36 Mexico Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 37 Mexico Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 38 Mexico Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 39 Rest of North America Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 40 Rest of North America Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 41 Rest of North America Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 42 Rest of North America Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 43 Rest of North America Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 44 Rest of North America Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 45 Key Information – Emergent BioSolutions, Inc.
TABLE 46 key Information – CSL Limited
TABLE 47 key information – Grifols S.A.
TABLE 48 Key Information – Octapharma AG
TABLE 49 Key Information – Takeda Pharmaceutical Company Limited
TABLE 50 key Information – Kedrion S.p.A
TABLE 51 Key Information – LFB S.A
TABLE 52 key information – Biotest AG
TABLE 53 Key Information – Sanquin Blood Supply Foundation
TABLE 54 Key Information – Bio Products Laboratory Limited
List of Figures
FIG 1 Methodology for the research